BRISTOL MYERS SQUIBB CO (BMY)
Clinical trial NCT05232643 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2026-01-30 → 2025-11-30 3. primary completion date: 2026-01-30 → 2025-11-30 4. enrollment: 720 → 636 participants 5. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical